TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 83 filers reported holding TANGO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,293,324 | +330.1% | 114,860 | +26.8% | 0.00% | – |
Q2 2023 | $300,682 | -6.2% | 90,567 | +11.6% | 0.00% | – |
Q1 2023 | $320,578 | -36.9% | 81,159 | +15.9% | 0.00% | – |
Q4 2022 | $507,747 | -48.9% | 70,034 | -74.5% | 0.00% | – |
Q3 2022 | $994,000 | +173.1% | 274,586 | +241.5% | 0.00% | – |
Q2 2022 | $364,000 | -52.8% | 80,395 | -21.0% | 0.00% | – |
Q1 2022 | $772,000 | -14.6% | 101,786 | +23.2% | 0.00% | – |
Q4 2021 | $904,000 | – | 82,606 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |